Skip to main content
. Author manuscript; available in PMC: 2019 Jul 24.
Published in final edited form as: Open Epidemiol J. 2011 Jan 19;4:3–29. doi: 10.2174/1874297101104010003

Table 1.

Comparison of Strengths and Weaknesses in Epidemiologic and Experimental Animal Studies

Strengths Weaknesses
Epidemiologic Studies Examination of exposure/effect relationships in species of interest Increased potential for exposure and outcome misclassification and confounding
Often able to study effects in heterogeneous population Limited measures of exposure and dose lead to challenges in characterizing quantitative dose-response relationships
Better suited to consider true range of population exposures Can take longer time to observe effects from exposure
Exposures better reflect temporal nature and delivery mechanism Relatively more expensive
Evaluate cumulative exposures and health impacts Confounding exposures/risk factors
Experimental Animal Studies Allow for examination of full spectrum of toxic effects Extrapolations required (interspecies, dose, temporal)
Facilitates estimation of quantitative dose-response relationships Dose delivery is artificial and poorly approximates true patterns of exposure
Reduced misclassification of exposures and outcomes Homogeneity of experimental animals in genetics, lifestage, diet, and initial health state
Study times can be shorter and allow for early indication of harm